two medical laboratories under happy news akira becken passed multiple external quality reviews through nccl.-尊龙凯时

in the national external quality evaluation of clinical laboratories in 2019 organized by the national health commission clinical laboratory center (nccl) of the ministry of health, two medical laboratories under dishuo becken’s banner, shanghai dishuo becken medical laboratory and shenzhen dishuo becken medical laboratory, participated in bcr-abl1 fusion. the quality evaluation of many testing items, such as syngenesis test, hla genotyping test and thalassemia gene test, passed with full marks. the evaluation results fully demonstrate the advanced technical strength, standard inspection standards and perfect quality management system of dishuo becken.

上海荻硕贝肯医学检验所评价结果

evaluation results of becken medical laboratory in dishuo, shenzhen

ucla immunogenetics center evaluation results

dishuo becken always upholds and implements strict quality objectives and actively participates in the external quality assessment activities organized by domestic and foreign authorities every year. the first external quality assessment in 2019 was organized by ucla immunogenetics center, which participated in by shanghai dishuo becken medical laboratory. hla (human leukocyte antigen) genotyping (ssp sso sbt) was evaluated at s level.

hla genotyping is a traditional advantage project of besuo beacon. it participates in the inter-room quality evaluation activities at home and abroad every year, and all of them have passed the consistency evaluation. this fully proves that the test project of susuo beacon is mature and stable, and the results are reliable.

about inter-room quality assessment

eqa (external quality assessment) is a process in which multiple laboratories analyze the same specimen and collect and report the results reported by the laboratory from an independent independent agency to evaluate the laboratory’s operation. the laboratory’s calibration, detection capabilities, and monitoring of its sustainability are determined by inter-laboratory comparisons. participation in the eqa program provides objective evidence of the reliability and effectiveness of the data produced by the evaluation laboratory.

the national health care committee clinical laboratory center (nccl) undertakes the national clinical inspection quality management and control work entrusted by the ministry of health, runs the national clinical laboratory quality evaluation plan, establishes and applies clinical test reference systems, and carries out related scientific research. nccl conducts a nationwide inter-room quality assessment program for major clinical testing programs. at present, there are 122 evaluation programs covering clinical biochemistry, immunology, blood and body fluids, microbiology, molecular biology, blood transfusion testing, etc., including about 315 inspection projects. the nccl inter-room quality assessment program operational capability verification program provider international standard (iso/iec 17043) quality system, and 376 inspection project inter-room quality assessment programs are approved by the china national accreditation service for conformity assessment (cnas) proficiency testing providers.

ucla immunogenetics center (uic) is one of the world’s oldest histocompatibility and immunogenetics laboratory dedicated to the research, clinical innovation, education and training and proficiency testing advancing the field of development. uic is an internationally recognized reference laboratory for the direction of histocompatibility and immunogenetics. it is the cms (centers for medicare and medicaid services) certification and the american society for organisms and immunogenetics (american society for histocompatibility and immunogenetics, ashi) accredited laboratory quality assessment activities.